In this episode of StrykerTalks, Andrés Rosales, VP and General Manager Endoscopy, delves into Stryker's groundbreaking 1788 visualization platform and and its potential to revolutionize surgical procedures. The 1788 visualization platform, Stryker's 26th generation camera, enables surgeons to see more so they can do more by visualizing tissue perfusion and illuminating cancer cells, ultimately improving patient outcomes.

Rosales also discusses the newly 510(k) cleared SPY-PHI for lymphatic mapping within breast cancer, offering surgeons a more efficient and patient-friendly alternative to traditional radioactive markers.

The innovation continues as Rosales hints at the future of Stryker's technology, emphasizing the role of data collection and algorithm development in improving surgical procedures.

Tune in to discover how Stryker is setting new standards in surgical visualization and how Stryker is collaborating with customers to create meaningful tools that improve the patient experience.

Thank you to GlobalMed-MDI for sponsoring this episode. To learn more about how GlobalMed-MDI works with medical device companies, visit www.moldeddevices.com.

Thank you for listening to the StrykerTalks Podcast.

Subscribe to this podcast on every major podcast platform

Andrés Rosales talks Stryker's FDA wins with 1788 visualization and SPY-PHI technology

In this episode of StrykerTalks, neurovascular president Jim Marucci discusses the company's latest advancements in neurovascular technology and how that, and its expanding global footprint, are shaping the future of its neurovascular division.

Marucci details the company's recent strategic acquisition of Cerus Endovascular, which has increased Stryker's capabilities in treating wide-neck bifurcated aneurysms. Furthering Stryker's goal to simplify procedures, reduce costs, and improve patient outcomes.

The conversation also touches on developing new products like the Target Tetra detachable coil for smaller aneurysms and the potential of emerging technologies like AI, AR, and VR in neurovascular procedures. Marucci anticipates these technologies will play a crucial role in advancing the field and improving access to care globally.

Tune in for a comprehensive overview of Stryker's current strategies, product innovations, and future directions in the neurovascular sector, underlining its commitment to enhancing stroke care and neurovascular treatments worldwide.

Thank you to Zeus for sponsoring this episode. To learn more about how Zeus works with medical device companies, visit www.zeusinc.com. 

Thank you for listening to the StrykerTalks Podcast.

Subscribe to this podcast on every major podcast platform.

Stryker’s neurovascular president Jim Marucci on Cerus acquisition, Target Tetra and AI/AR potential

In this episode of StrykerTalks, Spencer Stiles, Group President of Orthopaedics and Spine at Stryker, discusses Stryker's latest advancements shaping the future of orthopedics and spine care, including an update on the significant role of Mako, Stryker’s pioneering robotic arm-assisted system.

Additionally, Stiles discusses the expansive reach of these innovations, emphasizing their rapid adoption across global markets, particularly in Asia, where Stryker’s advanced solutions meet diverse clinical needs and operational settings. He shares insights into how these technologies cater to the unique challenges faced in different regions, enhancing Stryker's impact on global healthcare landscapes. The conversation further explores Stryker’s strategic growth initiatives, particularly its approach to mergers and acquisitions. Stiles outlines how these moves are carefully crafted to align with Stryker’s long-term vision, ensuring that each acquisition not only expands their market presence but also complements their existing portfolio. 

Thank you to DornerWorks for sponsoring this episode. To learn more about how DornerWorks supports medical device companies, visit www.DornerWorks.com. 

Thank you for listening to the StrykerTalks Podcast.

Subscribe to the DeviceTalks Podcast Network on every major podcast platform.

Spencer Stiles on what's driving Stryker’s ortho growth with surgical robotics and strategic M&A

In this episode of StrykerTalks, we welcome back Andy Pierce, Group President of MedSurg and Neurotechnology, to discuss the impact of the Vocera acquisition and how Vocera's dynamic clinical workflow addresses staffing shortages and enhances efficiency. 

Additionally, the episode covers Stryker's new LIFEPAK 35 monitor/defibrillator, advancements in the 1788 visualization platform, and ongoing innovations in the neurovascular space. Pierce also touches on plans for incorporating Vocera into more Stryker products and the company's interest in soft-tissue surgical robotics.

Want more from Andy Pierce? Explore his previous appearances on the DeviceTalks Podcast Network.

Prior appearance on StrykerTalks:
https://www.devicetalks.com/pierce-talks-innovation-vocera-ascs-and-why-nurses-hug-strykers-neptune-waste-management-system/

Prior appearance on DT Weekly:
https://www.devicetalks.com/lobo-and-pierce-talk-wright-cool-tech-robotics-and-the-not-so-secret-plans-to-keep-stryker-growing/

Thank you to S2 Insight, Inc. for sponsoring this episode. To learn more about how S2 Insight, Inc. supports medical device companies, visit https://www.s2insight.com/case-studies. 

Thank you for listening to the StrykerTalks Podcast. 

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Stryker’s Pierce updates on Vocera, 1788, Neuro, & interest in soft-tissue surgical robotics system

In this StrykerTalks episode, Andy Pierce, Group President of MedSurg and Neurotechnology at Stryker, shares his insights on the company’s commitment to innovation, growth, and patient-centered care. 

Pierce reflects on his 29-year journey with Stryker, highlighting the high-performance culture shaped by entrepreneurial spirit, growth targets, and strategic acquisitions. He discusses how Stryker’s decentralized structure supports quick, localized decision-making while fostering collaboration across its business units. 

The conversation also explores the company's M&A strategy, focusing on acquisitions that bring de-risked, high-impact technologies that align with Stryker’s long-term goals. Pierce provides an inside look at Stryker's engagement with the soft tissue robotics space, its approach to balancing internal and external innovation, and the proactive steps Stryker takes to address healthcare staffing shortages with technology.

Thank you to Vantedge Medical for sponsoring this episode. To learn more about how Vantedge Medical works with medical device companies, visit www.vantedgemedical.com

Thank you for listening to the StrykerTalks Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Andy Pierce shares how Stryker is “fighting on its front foot” through R&D and aggressive M&A

The DeviceTalks Podcast Network delivers news, insights and commentary from MedTech industry leaders, primarily from the largest OEMs in healthcare. Our podcasts will inspire MedTech professionals to create better MedTech devices and companies.

Explore the DeviceTalks Podcast Network, home to more than 11 podcasts:

• DeviceTalks Weekly
• AbbottTalks
• Boston Scientific Talks
• DeviceTalks AI
• IntuitiveTalks
• MedtechWOMEN Talks
• MedtronicTalks
• Neuro Innovation Talks: J&J MedTech Neuro
• Structural Heart Talks: Edwards Lifesciences
• Ortho Innovation Talks: Zimmer Biomet
• StrykerTalks

WATCH our video podcasts on www.youtube.com/@DeviceTalks

Connect with the hosts:
Tom Salemi, Editorial Director, DeviceTalks https://www.linkedin.com/in/tom-salemi-7118948/
Kayleen Brown, Managing Editor, DeviceTalks https://www.linkedin.com/in/kayleenbrown/

Learn more about DeviceTalks - Podcasts • Conferences • Webinars - www.devicetalks.com

New tracks tagged #StrykerTalks